Rubicon Research

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE506V01022
  • NSEID: RUBICON
  • BSEID: 544578
INR
648.15
-15.7 (-2.36%)
BSENSE

Jan 21

BSE+NSE Vol: 85.33 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

85.33 k (48.75%) Volume

Shareholding (Jul 2024)

FII

0.00%

Held by 0 FIIs

DII

15.85%

Held by 2 DIIs

Promoter

84.15%

Which are the latest news on Rubicon Research?

20-Jan-2026
No latest news for Rubicon Research found.

Why is Rubicon Research falling/rising?

21-Jan-2026

As of 20-Jan, Rubicon Research Ltd's stock price is at 659.45, down 0.71%, and has declined 3.38% over the last three days. It is underperforming against the Sensex and has seen reduced investor participation, indicating short-term weakness despite trading above longer-term moving averages.

As of 20-Jan, Rubicon Research Ltd's stock price is falling, currently at 659.45, reflecting a change of -4.7 (-0.71%). The stock has been on a downward trend, having lost -3.38% over the last three days. Additionally, it has underperformed compared to the benchmark Sensex over the past week, with a decline of -2.59% versus the Sensex's -1.73%. <BR><BR>Today's trading session saw the stock touch an intraday low of Rs 649.45, indicating a significant drop of -2.21%. The stock's performance is also impacted by the broader sector, as the Pharmaceuticals & Drugs sector has fallen by -2.15%. Furthermore, there is a notable decrease in investor participation, with delivery volume on 19 January falling by -11.52% compared to the five-day average. <BR><BR>While the stock is trading above its 100-day and 200-day moving averages, it is below its 5-day, 20-day, and 50-day moving averages, suggesting a short-term weakness. Overall, these factors contribute to the current decline in Rubicon Research Ltd's stock price.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 10,678 Cr (Mid Cap)

stock-summary
P/E

65.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.60

stock-summary
Return on Equity

22.13%

stock-summary
Price to Book

14.35

Revenue and Profits:
Net Sales:
412 Cr
(Quarterly Results - Sep 2025)
Net Profit:
54 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.93%
0%
5.93%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Rubicon Research for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
6.94
Debt to EBITDA (avg)
2.05
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.27
Tax Ratio
24.96%
Dividend Payout Ratio
0.23%
Pledged Shares
0
Institutional Holding
19.92%
ROCE (avg)
22.12%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
65
Industry P/E
0
Price to Book Value
14.35
EV to EBIT
47.57
EV to EBITDA
41.93
EV to Capital Employed
9.36
EV to Sales
10.54
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
19.68%
ROE (Latest)
22.13%

Technicals key factors

Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jul 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

General Atlantic Singapore Rr Pte Ltd (35.97%)

Highest Public shareholder

Shivanand Shankar Mankekar Huf (13.57%)

Individual Investors Holdings

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 21.02% vs 9.07% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 30.33% vs -18.05% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "336.47",
          "val2": "278.03",
          "chgp": "21.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "79.11",
          "val2": "63.15",
          "chgp": "25.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.21",
          "val2": "8.85",
          "chgp": "4.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "45.81",
          "val2": "35.15",
          "chgp": "30.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.51%",
          "val2": "22.71%",
          "chgp": "0.80%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "614.49",
          "val2": "528.16",
          "chgp": "16.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "142.24",
          "val2": "144.68",
          "chgp": "-1.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.06",
          "val2": "16.26",
          "chgp": "11.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "80.96",
          "val2": "89.04",
          "chgp": "-9.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.15%",
          "val2": "27.39%",
          "chgp": "-4.24%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Jun'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "806.19",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "207.83",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "25.11",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "124.19",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.78%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,073.84",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "269.89",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "34.29",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "167.54",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.13%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQstock-summary

Sep'25
Jun'25
Change(%)
Net Sales
336.47
278.03
21.02%
Operating Profit (PBDIT) excl Other Income
79.11
63.15
25.27%
Interest
9.21
8.85
4.07%
Exceptional Items
0.00
0.00
Standalone Net Profit
45.81
35.15
30.33%
Operating Profit Margin (Excl OI)
23.51%
22.71%
0.80%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 21.02% vs 9.07% in Jun 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 30.33% vs -18.05% in Jun 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
614.49
528.16
16.35%
Operating Profit (PBDIT) excl Other Income
142.24
144.68
-1.69%
Interest
18.06
16.26
11.07%
Exceptional Items
0.00
0.00
Standalone Net Profit
80.96
89.04
-9.07%
Operating Profit Margin (Excl OI)
23.15%
27.39%
-4.24%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Nine Monthly Results Snapshot (Standalone) - Jun'25stock-summary

Jun'25
Change(%)
Net Sales
806.19
NA
NA
Operating Profit (PBDIT) excl Other Income
207.83
NA
NA
Interest
25.11
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
124.19
NA
NA
Operating Profit Margin (Excl OI)
25.78%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Change(%)
Net Sales
1,073.84
NA
NA
Operating Profit (PBDIT) excl Other Income
269.89
NA
NA
Interest
34.29
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
167.54
NA
NA
Operating Profit Margin (Excl OI)
25.13%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Rubicon Research Ltd stock-summary
stock-summary
Rubicon Research Ltd
Mid Cap
Pharmaceuticals & Biotechnology
Rubicon Research Limited was incorporated on May 6, 1999, as a Private Company as `Rubicon Consultants Private Limited', with the RoC. Subsequently, the Company's name was changed from `Rubicon Consultants Private Limited' to `Rubicon Research Private Limited' to which a fresh Certificate of Incorporation was issued by the RoC dated September 2, 2002.
Company Coordinates stock-summary
Icon
No Company Details Available